www.atg-biosynthetics.com

Integrated Synthetic BioPharma Projects are much more than simply providing a New Technology –  there is need for solid informational basis and stringent project management.

ATG:biosynthetics GmbH is a German company that develops and organises with partners integrated biopharma and technology projects based on new technologies in synthetic biology for economical production of bioactive molecules like - biopharmaceuticals and xeno-biochemicals.

Integrated Synthetic BioPharma Projects are much more than simply  providing  a New Technology – there is need for solid informational basis and stringent project management. Considering this experiences ATG supports your ATG - Integrative BioPharma - Projects with high impact on the development of New Markets on the basis of New Technologies for Future Economy.

ATG:biosynthetics GmbH/ Germany
Dr. Hubert S. Bernauer, CEO
Weberstr. 40
79249 Merzhausen
Germany

Tel. +49 (0) 761-88 89 424
Fax +49 (0) 761-88 89 425
Mobile +49 (0) 179/ 66 07 141
eMail:info@atg-biosynthetics.de
Web: www.atg-biosynthetics.de